Scientists propose a new model for Alzheimer’s disease that may explain the high failure rate of recent clinical trials.
Deficiency of a protein in the hippocampus is a major cause of age-related memory loss, and this form of memory loss is reversible, according to Columbia researchers.
Key molecular pathways that lead to Alzheimer's identified—a new approach to Alzheimer’s research; several potential drug targets highlighted.
Ottavio Arancio, MD, PhD, of CUMC's Taub Institute, coauthored a paper on a compound that prevents memory loss in a mouse model of Alzheimer's. See Northwestern's news release: http://bit.ly/14Zqwwn
Mouse study suggests inhibiting protein called caspase-2 might prevent cognitive decline in Alzheimer's
Columbia University study looks at the relationship between families with exceptional longevity and cognitive impairment consistent with Alzheimer's disease.